Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,350 | 12,982 | 19,473 | 105,833 | 18,079 |
| Marketable Securities | 64,327 | 110,216 | 61,779 | N/A | N/A |
| Receivables | 40,803 | 38,063 | 29,196 | 18,568 | 14,486 |
| Inventories | 39,255 | 29,245 | 19,330 | 10,561 | 7,820 |
| TOTAL | $161,402 | $198,359 | $133,402 | $137,972 | $40,978 |
| Non-Current Assets | |||||
| PPE Net | 25,953 | 22,298 | 15,338 | 2,849 | 829 |
| Intangibles | 20,890 | 21,840 | 0 | 0 | 0 |
| Other Non-Current Assets | 8,849 | 9,410 | 10,284 | 0 | 0 |
| TOTAL | $55,692 | $53,548 | $25,622 | $2,849 | $829 |
| Total Assets | $217,094 | $251,907 | $159,024 | $140,821 | $41,807 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,788 |
| Accounts payable and accrued liabilities | 10,522 | 11,835 | 8,668 | 4,056 | 2,265 |
| Accrued Expenses | 23,893 | 28,766 | 21,238 | 14,154 | 7,544 |
| Other current liabilities | 510 | 4,432 | 339 | N/A | N/A |
| TOTAL | $34,925 | $45,033 | $30,245 | $18,210 | $11,597 |
| Non-Current Liabilities | |||||
| Long Term Debt | 53,306 | 53,008 | 52,711 | 29,538 | 29,434 |
| Other Non-Current Liabilities | 15,971 | 15,928 | 15,539 | 0 | 0 |
| TOTAL | $69,277 | $68,936 | $68,250 | $29,538 | $29,434 |
| Total Liabilities | $104,202 | $113,969 | $98,495 | $47,748 | $41,031 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,619 | 61,755 | 61,156 | 54,748 | N/A |
| Common Shares | 62 | 62 | 55 | 45 | 28 |
| Retained earnings | -189,990 | -134,247 | -84,720 | -41,905 | -21,353 |
| Other shareholders' equity | -184 | 150 | -27 | 0 | 0 |
| TOTAL | $112,892 | $137,938 | $60,529 | $93,073 | $776 |
| Total Liabilities And Equity | $217,094 | $251,907 | $159,024 | $140,821 | $41,807 |